(5E)-5-{[(4-bromophenyl)amino]methylidene}-3-methyl-1,3-thiazolidine-2,4-dione

Catalog No. :
ACQJMP828
CAS No. :
478081-27-5
Molecular Formula :
C11H9BrN2O2S
Molecular Weight :
313.18

IUPAC Name:(E)-5-(((4-bromophenyl)amino)methylene)-3-methylthiazolidine-2,4-dione

(5E)-5-{[(4-bromophenyl)amino]methylidene}-3-methyl-1,3-thiazolidine-2,4-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(5E)-5-{[(4-bromophenyl)amino]methylidene}-3-methyl-1,3-thiazolidine-2,4-dione
IUPAC Name(E)-5-(((4-bromophenyl)amino)methylene)-3-methylthiazolidine-2,4-dione
MDL No.MFCD01871707
Molecular FormulaC11H9BrN2O2S
Molecular Weight313.18
SMILESCN1C(=O)S/C(=C/NC2=CC=C(Br)C=C2)C1=O
InChI KeyNADZSSOKFQALQP-RMKNXTFCSA-N
Synonym5-[(E)-(4-BROMOANILINO)METHYLIDENE]-3-METHYL-1,3-THIAZOLANE-2,4-DIONE;(5E)-5-{[(4-bromophenyl)amino]methylidene}-3-methyl-1,3-thiazolidine-2,4-dione;2,4-Thiazolidinedione, 5-[[(4-bromophenyl)amino]methylene]-3-methyl-
CAS No.478081-27-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACQJMP828 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQJMP828 route product structure diagram
    ACQJMP828478081-27-5
Inquiry

2. ACQJMP828 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDNVB185 route compound structure diagram
    ACDNVB18516312-21-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQJMP828 route product structure diagram
    ACQJMP828478081-27-5
Inquiry

Comments (0)